Media Assistance:
 Joni Westerhouse Executive Director for Medical Communications westerhousej@wustl.edu (314) 286-0120 |
The Division of Hematology was founded in 1938 by Carl V. Moore, M.D., and the three main goals established at its inception -- research, teaching and clinical care -- remain in place today.
The Division of Hematology employs full-time faculty members who epitomize excellence in basic and clinical science. The focus of the Division is on non-malignant disorders including diseases of red blood cells, platelets, and the coagulation and fibrinolytic pathways.
| News Stories & Tip Sheets: |
|
Showing Stories 1 through 3 of 14. - Show More |
|
| Treating sickle cell with stem cells Stem cell transplant for sickle cell disease subject of clinical trial (http://mednews.wustl.edu/news/page/normal/12009.html) July 11, 2008 -- Children with sickle cell disease often face severe pain, organ damage, recurrent strokes and repeated, prolonged hospital stays. Although there are medical interventions that can lessen the symptoms, there is no cure. Researchers at the School of Medicine are leading a nationwide, multicenter clinical trial to determine the effectiveness of transplanting blood stem cells from unrelated donors into children with severe sickle cell disease. |
| New blood Blood transfusions help children with sickle cell disease and silent strokes (http://mednews.wustl.edu/news/page/normal/10714.html) Dec. 10, 2007 -- A group of children who have sickle cell disease and who experience silent strokes showed some relief from the silent strokes with blood transfusion therapy, researchers at the School of Medicine have found. The study's results will appear in a future issue of Pediatric Blood and Cancer but are available for review in its advance online publication. |
| First-of-its-kind procedure Bone marrow transplant performed for sickle cell disease (http://mednews.wustl.edu/news/page/normal/10151.html) Sept. 25, 2007 -- Bone marrow transplants are best known for their potential to cure people with certain types of cancer. But they also hold promise for people with severe cases of sickle cell anemia, also known as sickle cell disease. Now, in a first-of-its-kind procedure, St. Louis Children's Hospital has performed a bone marrow transplant in a teenager with sickle cell disease, using cells from a donor who is unrelated to him. |
|
Showing Stories 1 through 3 of 14. - Show More |
|
| Faculty Experts: |
|
Showing 1 Experts. |
|
| John DiPersio Chief of the Division of Bone Marrow Transplantation and Stem Cell Biology (http://mednews.wustl.edu/sb/page/normal/232.html) DiPersio helped pioneer stem cell transplants and now focuses his research efforts on improving the success of bone marrow and stem cell transplants for the treatment of cancer and disorders of the blood. He is investigating the use of gene therapy to control graft versus host disease that is a main ... Expertise: bone marrow transplantation, leukemia/lymphoma, stem cell transplantation, graft vs. host disease Media assistance: (314) 286-0141 / ericsong@wustl.edu |
|
Showing 1 Experts. |
|
| Related News Clips: |
|
Showing 1 Clips. |
|
| 'Bloodless' surgery offers an alternative to transfusion
Detroit Free Press and 1 others June 3, 2004 -- A bloodless medicine program offers alternatives for those who do not want blood, and helps to save the supply for those who need it. "What is going to drive conservation of blood is inventory," said Lawrence Goodnough, M.D., professor of medicine at the School of Medicine. "We're kind of skating along with low inventories." Some people will always need donated blood, Goodnough said. "Who are we saving the blood supply for? For trauma cases or bone marrow transplants or newly diagnosed conditions and people who can't plan ahead." The best candidates for bloodless medicine are patients undergoing scheduled or elective procedures. These allow time to take the patient's blood count and make a treatment plan. |
|
Related Information Related Groups:
|